- Research Article
- 10.46531/sinapse/ao/210033/2021
Clinical Characterisation of Wilson’s Disease Patients and Predictors of Neurological Involvement: A Retrospective Study at a Tertiary Care Centre in Lisbon
- Oct 14, 2021
- Sinapse
- José Rosa
Introduction: Wilson's disease (WD) is an autosomal recessive metabolic disorder caused by ATP7B gene mutations, producing toxic copper accumulation, mainly in the liver and the brain.We aim to characterise the population of patients with WD followed at our centre and to identify possible factors that may correlate with neurological involvement in WD.Methods: We identified all patients with the diagnosis of WD listed in our centre's database between 2009 and 2017.We reviewed case records and collected clinical, laboratorial, genetic and imaging data.Results: We identified 24 patients, 17 (71%) of which were females.The median age at diagnosis was 17 years.ATP7B gene sequencing result reported c.2123T>C as the most frequent mutation.The mixed hepatic and neurological presentation was the most common form (45.8%, 11 cases).Pure hepatic and neurological presentations were found in 10 (41.7%) and 3 (12.5%)patients, respectively.Rigidity, bradykinesia and tremor were the most reported neurological signs, with bradykinesia being more frequent in the younger patients.Normal liver transaminase levels at diagnosis correlated with the presence of neurological disease (p<0.01).Six patients with neurological symptoms presented brain magnetic resonance imaging changes compatible with WD.Follow-up reported improvement with treatment in 8/11 (73%) patients with neurological symptoms.Conclusion: Initial assessment of liver transaminase levels may help to identify WD patients who are more likely to develop in time neurological symptoms, alerting to the need for regular neurological evaluations.
Read more